Video narration
How can one injection raise a slow heart rate and also matter in organophosphate poisoning? Like a clinical vignette, one mechanism explains both. Atropine blocks muscarinic acetylcholine receptors; it does not generally stimulate the heart. In appropriate bradycardia, vagal acetylcholine slows the heart through M2 receptors-the heart's vagal brake. Block them; the rate rises. The contradiction disappears: atropine neither stimulates the heart nor removes the poison. It blocks muscarinic effects in both. Organophosphates cause acetylcholine to build up, producing muscarinic toxicity, including excess secretions and a slow heart rate. Atropine counters these effects. But it does not reverse nicotinic muscle weakness. Watch for dry mouth, blurred vision, urinary retention, or tachycardia; route and monitoring depend on the emergency and local protocol. So, why both roles? One blockade reduces vagal slowing in the heart and muscarinic toxicity in poisoning.